The National Asthma Council Logo

 

 

Leading the attack against asthma

Search website
Home About the NAC Strategy Managing Asthma Research Emergency
 
Asthma Information Papers
 
Asthma Management Handbook Asthma Action Plans Spirometry Resources  Other Resources Information Papers Special Topics Professional Development  

Asthma Information Papers

Roles of influenza and pneumococcal vaccinations
Influenza vaccination overview
Case for Influenza Vaccination
Potential benefits for people with asthma
Potential benefits for people with COPD
Potential benefits for people with cardiovascular disease
Potential benefits for people with diabetes
Pneumococcal vaccination overview
Case for Pneumococcal Vaccination
Potential benefits in specific high-risk groups
References
Content created May 2005
Content updated Feb 2006


Get Adobe Reader

Get Adobe Flash Player

 

Roles of influenza and pneumococcal vaccinations

in subgroups with asthma, COPD, diabetes or heart disease

Introduction

Vaccination of persons at risk of complications from influenza and pneumococcal disease is a key public health strategy for preventing associated morbidity and mortality. Those most at risk include people aged 65 years and older, and people with medical conditions that increase the likelihood of complications from infections, for example, chronic respiratory diseases, diabetes and cardiovascular disease. Influenza vaccination programs have been shown to reduce morbidity and mortality associated with infection in high-risk groups,1 prevent exacerbations and acute respiratory illness in those with chronic lung disease2 and reduce future ischaemic events in people with myocardial infarction.3 Pneumococcal vaccination has been shown to reduce the incidence of invasive pneumococcal disease in children and adults, including those with chronic conditions.4,5

NextBack
Roles of influenza and other vaccinations

For further information about asthma

visit the National Asthma Council website at www.nationalasthma.org.au

For further information about diabetes

visit the Diabetes Australia website at www.diabetesaustralia.com.au

For further information about heart health

visit the Heart Foundation website at www.heartfoundation.com.au

For further information about COPD

visit the Australian Lung Foundation website at www.lungnet.com.au

Acknowledgements

This brochure has been sponsored by

CSL Pharmaceuticals

 

National Asthma Council Australia
ABN 61 058 044 634
Suite 104, Level 1
153-161 Park Street
South Melbourne VIC 3205
Australia
Tel: (+61) 3 9929 4333    Email: nac@nationalasthma.org.au
Fax: (+61) 3 9929 4300    Website: www.nationalasthma.org.au
May 2005 (updated February 2006)

Disclaimer

Although all care has been taken, this brochure is a general guide only which is not intended to be a substitute for individual medical advice/treatment. The National Asthma Council expressly disclaims all responsibility (including for negligence) for any loss, damage or personal injury resulting from reliance on the information contained.